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Chronic inflammation imposes aberrant cell fate in
regenerating epithelia through mechanotransduction
Craig S. Nowell1,7,8, Pascal D. Odermatt2, Luca Azzolin3, Sylke Hohnel4, Erwin F. Wagner5, Georg E. Fantner2,
Matthias P. Lutolf4, Yann Barrandon6, Stefano Piccolo3 and Freddy Radtke1,8
Chronic inflammation is associated with a variety of pathological conditions in epithelial tissues, including cancer, metaplasia and
aberrant wound healing. In relation to this, a significant body of evidence suggests that aberration of epithelial stem and
progenitor cell function is a contributing factor in inflammation-related disease, although the underlying cellular and molecular
mechanisms remain to be fully elucidated. In this study, we have delineated the effect of chronic inflammation on epithelial
stem/progenitor cells using the corneal epithelium as a model tissue. Using a combination of mouse genetics, pharmacological
approaches and in vitro assays, we demonstrate that chronic inflammation elicits aberrant mechanotransduction in the
regenerating corneal epithelium. As a consequence, a YAP–TAZ/β-catenin cascade is triggered, resulting in the induction of
epidermal differentiation on the ocular surface. Collectively, the results of this study demonstrate that chronic inflammation and
mechanotransduction are linked and act to elicit pathological responses in regenerating epithelia.
Chronic inflammation is associated with a variety of pathologies in
self-renewing epithelial tissues, including impaired wound healing,
metaplasia and cancer1–3. Indeed, several studies have demonstrated
that chronic inflammation is in fact a key driver of aberrant
function in epithelial cells4–7, although the underlying mechanisms
are only beginning to be elucidated. Of particular interest is
how stem/progenitor cells in self-renewing epithelia are affected
by exposure to a chronic inflammatory environment, especially as
aberrant stem cell function is associated with diseases linked to
chronic inflammation7–10.
Previous studies have shown that chronic inflammation can exert
a direct effect on epithelial stem/progenitor cells by secreting soluble
factors that regulate key signalling cascades controlling stem cell
function11–13. However, in addition to regulation by soluble factors
such as cytokines and growth factors, stem cells are also regulated
by a variety of other microenvironmental cues. In particular, the
mechanical properties of tissues can profoundly influence cellular
responses and can exert a dominant influence on their response to the
mileu of extrinsic factors present in the tissue stroma/niche14,15.
Mechanical cues, such as elasticity and topography, are heavily
influenced by the deposition and organization of extracellular matrix
(ECM) proteins16–19, which are secreted by stromal cell types such
as tissue-resident fibroblasts16,19. Interestingly, a hallmark of many
chronic inflammatory conditions is fibrosis, in which excessive ECM
deposition occurs in response to persistent inflammation20–22. This
therefore raises the possibility that at least some of the effects of
chronic inflammation may be a consequence of altered mechanical
cues downstream of fibrosis. Thus, understanding the link between
chronic inflammation and tissue mechanical properties may identify
new therapeutic targets.
The corneal epithelium (CE), which forms a protective barrier
on the anterior ocular surface, is a clinically relevant example of a
self-renewing epithelium in which chronic inflammation is closely
associated with abnormal function.
The CE is a stratified epithelium that resides on a relatively simple,
avascular stroma and which is maintained during homeostasis and
repair by corneal epithelial stem cells23 (CESCs). At present, the
precise identity of CESCs is unknown as stem-cell-specificmarkers are
lacking. However, label-retaining experiments and functional assays
indicate that they reside predominantly, although not exclusively,
at the limbus, a junctional zone between the cornea and the
conjunctiva24,25. Importantly, stem cells isolated from the limbus can
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be used clinically to reconstitute the corneal epithelium following
injury or disease, either by direct transplantation or by grafting
in vitro-expanded cultures of limbal stem cells26.
Chronic inflammation has a profound effect on the function of
CESCs, and is associated with poor outcome in limbal transplanta-
tion27 and with conditions such as corneal squamous cell metaplasia
(CSCM), in which the CE adopts a keratinizing, skin-like fate28–30.
We have previously shown that loss of Notch1 in the mouse CE
promotes the development of CSCM specifically during repair31. In
this model CSCM is induced following remodelling of the underlying
corneal stroma by the Notch1-deficient CE and is thus a consequence
of changes in the surrounding microenvironment. Interestingly, in
other stratified epithelial tissues, such as the skin, Notch signalling
has been shown to negatively regulate inflammation32,33, raising the
possibility that an aberrant inflammatory response during wound
healing may play a role in promoting CSCM in Notch1 mutants. In
this study, we have used Notch1 mutant mice as a means to investigate
the significance of inflammation during CSCM induction and have
specifically explored the link between inflammation and mechan-
otransduction in mediating cell fate alterations.
RESULTS
Chronic inflammation promotes CSCM
To investigate the role of inflammation in CSCM, we used
Notch1lox/lox :K5CreERT mice, in which tamoxifen-induced cre activ-
ity results in conditional deletion of Notch1 in the CE (ref. 31).
Consistent with our previous report, the unwoundedNotch1-deficient
(Notch11) cornea maintained corneal identity on the ocular surface,
as indicated by the expression of the corneal-specific cytokeratin 12
(K12), and exhibited a simple, relatively acellular stroma, and was
thus indistinguishable from wild-type (WT) controls (Supplementary
Fig. 1a). However, after repeated injury (Fig. 1a), Notch11 mice
developed corneal opacity and significant morphological changes
at the histological level (Fig. 1b). Specifically, the Notch11 corneal
stroma was infiltrated with large numbers of polymorphonuclear
neutrophils, indicative of an ongoing inflammatory response, and
exhibited CSCM, indicated by expression of the epidermal-specific
cytokeratin 1 (K1; Fig. 1b). In contrast, WT controls did not exhibit
any overt signs of inflammation and retained a K12+K1− corneal
epithelium, although K12−K1+ cells were present at the limbus
(Fig. 1b). Flow cytometric analysis confirmed that Notch11 corneas
contained increased numbers of CD45+ leukocytes both during
repair and at least 21 days after injury when wound closure had
occurred (Fig. 1c,d), with most infiltrating CD45+ cells exhibiting
a CD11b+Gr1+ phenotype (Supplementary Fig. 1b,c), indicative of
neutrophils. Furthermore, a variety of pro-inflammatory cytokines
exhibited significant upregulation in the Notch11 CE compared with
WT CE following injury (Fig. 1e). Collectively, the above findings
indicate that CSCM in Notch11 mice is closely associated with an
augmented and chronic inflammatory response.
In light of this, we sought to establish whether chronic
inflammation is both necessary and sufficient to induce epidermal
differentiation on the ocular surface. We therefore employed two
approaches. First, we aimed to abrogate the inflammatory response
in Notch11 mice to determine whether aberrant inflammation is
essential for CSCM in this model. Second, we aimed to establish
whether chronic inflammation is sufficient to induce CSCM in a
Notch-independent setting.
Regarding the former, we noted thatmany of the pro-inflammatory
cytokines upregulated in the Notch11 CE are targets of the
transcription factor AP-1. Furthermore, the Notch11 CE exhibited
increased phosphorylation of the AP-1 family member cjun at
Ser 73, indicative of activation (Supplementary Fig. 2a). We
therefore reasoned that persistent AP-1 activation in the Notch11
CE contributes to the chronic inflammatory response in Notch11
mice, consistent with previous reports34–36. We therefore generated
Notch1lox/lox :cjunlox/lox :K5CreERT mice and simultaneously ablated
Notch1 and cjun by tamoxifen treatment (Notch11:cjun1). Following
injury, Notch11:cjun1 mice exhibited a significantly reduced
inflammatory response compared with Notch11 mutants despite
Notch1 ablation (Supplementary Fig. 2b–e) and strikingly retained
a K12+K1− CE after repeated injury (Supplementary Fig. 2f–h),
supporting the hypothesis that chronic inflammation is essential for
the development of CSCM in Notch11 mice.
An important caveat to the experiments using the Notch11:cjun1
mice is that AP-1 regulates a variety of cellular functions in addition
to inflammation, including differentiation34,37,38, and thus an
autonomous effect cannot be ruled out. Therefore, to definitively
establish that inflammation is the key driver of CSCM in Notch11
mice, we administered a dexamethasone-based anti-inflammatory gel
(Tobradex) to the ocular surface during the repeated injury procedure
(Fig. 2a). Strikingly, Notch11 mice treated with Tobradex exhibited
a relatively normal corneal stroma and maintained a K12+K1− CE
(Fig. 2b), despite Notch1 ablation (Supplementary Fig. 2i), thus
confirming that chronic inflammation is essential for CSCM in
Notch11 mutants.
To establish whether chronic inflammation is sufficient for the
induction of CSCM in a Notch-independent setting, we performed
the repeated injury procedure on K14TSLPTg mice39, which develop
chronic inflammation in stratified epithelia due to the expression
of the pro-inflammatory cytokine TSLP (ref. 40; Fig. 2c). Strikingly,
K14TSLPTg mice exhibited a near identical phenotype to Notch11
mutants (Fig. 2d), confirming that chronic inflammation is indeed
sufficient for the induction of CSCM.
CSCM is induced in activated stem/progenitor cells located at
the limbus and peripheral cornea
We next sought to address the cellular and molecular mechanism by
which chronic inflammation promotes aberrant cell fate and to this
end usedNotch11mice as amodel of inflammation-associated CSCM.
Initially, we determined the spatial and temporal kinetics of CSCM
development inNotch11mice.Whole-mount immunofluorescence on
CE isolated after each injury–repair cycle demonstrated that CSCM
first became apparent after the second injury (Supplementary Fig. 3a).
This was characterized by the presence of K12−K1+ cells within the
Notch11 CE, particularly at the peripheral cornea in close proximity
to the limbus (Supplementary Fig. 3a). In contrast, WT CE remained
K12+K1−, although K12−K1+ epidermal cells were present in the
limbus to varying degrees (Supplementary Fig. 3a).
We therefore chose to analyse the second injury–repair cycle at 0, 6
and 24 h after injury, to determine when and where CSCM is induced.
In WT controls, K12+K1− cells predominated throughout the CE
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Figure 1 Corneal squamous cell metaplasia (CSCM) in Notch11 mice
is associated with an augmented and chronic inflammatory response.
(a) Schematic depiction of the experimental strategy. (b) Histology of
WT (Notch1lox/lox ) and Notch11 corneal tissue after repeated injury
(representative of 16 WT corneas and 20 Notch11 corneas). Upper panels:
haematoxylin and eosin (H&E) staining; lower panels: immunofluorescence
for K12, K1 and CD45. Large panels are low-magnification tiled images.
Insets on the upper left corner of the H&E images show gross phenotype on the
ocular surface. Black (H&E) and white (immunofluorescence) outlined insets
show high-magnification images of the indicated regions. (c,d) Quantification
of the proportion of CD45+ cells in WT and Notch11 corneas 24h after a
single injury (c) and 21 days after repeated corneal injury (d). Proportions
were measured by performing flow cytometry on dissociated corneas (n=6
biological replicates for each genotype over three independent experiments;
each replicate consists of cells pooled from 4 corneas isolated from 2 mice
of each genotype). (e) QRT–PCR analysis for the indicated cytokines in WT
(Notch1lox/lox ) and Notch11 corneal epithelial cells 24 h after a single corneal
injury. Data are expressed relative to the expression in WT unwounded corneal
epithelial cells (n= 6 biological replicates for each genotype over three
independent experiments; each replicate consists of corneal epithelial tissue
pooled from 6 corneas isolated from 3 mice of each genotype). Scale bars
represent 500 µm on tiled images and 5 µm on all other histological images.
Scale bars on images showing gross morphology of corneas represent 1mm.
Black and white dotted lines indicate the boundary between the stroma and
epithelium. St, stroma. ∗P<0.01, ∗∗P<0.05 (unpaired, two-tailed t-tests).
Error bars represent standard deviation.
at each stage of repair, although K12−K1+ cells were present in the
limbus (Fig. 3a,b), consistent with the observations fromwhole-mount
analysis (Supplementary Fig. 3a). In contrast, Notch11 mice exhibited
increasingly prominent areas of K12−K1+ cells extending from the
limbus into the peripheral cornea as wound healing progressed
(Fig. 3a,b). In addition, the epithelium in the limbus and peripheral
cornea of Notch11 mice was generally less stratified than in WT
controls (Fig. 3a). Consistent with the whole-mount analysis, no overt
phenotypic differences were apparent between WT and Notch11 CE
during the first injury–repair cycle (Supplementary Fig. 3b).
The above findings indicate that CSCM in Notch11 mice is
initially induced at the limbus/peripheral cornea and subsequently
170
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Figure 2 Chronic inflammation is necessary and sufficient to induce CSCM.
(a) Schematic depiction of the experimental strategy used to determine
whether chronic inflammation is necessary for the induction of CSCM in
Notch11 mice. (b) Immunofluorescent staining for K12, K1 and CD45
on Notch11 corneas treated with ophthalmic gel (control) or the anti-
inflammatory gel Tobradex. The images are representative of 6 corneas
per treatment over three independent experiments. Large panels are low-
magnification tiled images. Insets show high-magnification images of the
indicated regions. (c) Schematic depiction of the experimental strategy
used to determine whether chronic inflammation is sufficient to induce
CSCM. (d) Immunofluorescent staining for K12, K1 and CD45 on WT (non-
transgenic littermates) and K14TSLPTg corneas after the procedure shown
in c. The images are representative of 6 corneas per genotype over three
independent experiments. Large panels are low-magnification tiled images.
Insets show high-magnification images of the indicated regions. Scale bars
represent 500 µm on tiled images and 5 µm on all other images. White
dotted lines indicate the boundary between the stroma and epithelium.
St, stroma.
migrates to the site of injury as wound closure proceeds. This
is consistent with the model of corneal regeneration proposed
in a previous study, which found that cells mediating wound
healing are derived from stem/progenitors located in the limbus25.
In support of this, we observed increased proliferative activity in
the limbus and peripheral cornea following injury (Supplementary
Fig. 3c,d), suggesting activation of stem/progenitor cells specifically
within these regions. In addition, whole-mount immunofluorescence
on CE isolated after repeated injury revealed that metaplastic
K12−K1+ regions in Notch11 CE remained continuous with the
limbus/peripheral cornea, and thus conformed to the pattern expected
if CSCM derived from this region (Fig. 3c,d).
Chronic inflammation induces CSCM through elevation of
β-catenin signalling in the CE
At the molecular level, aberrant Wnt/β-catenin signalling has been
linked to squamous cell metaplasia in a variety of epithelial tissues,
including the cornea41–43, and is therefore a good candidate for
mediating CSCM in response to chronic inflammation. Consistent
with this, the Notch11 CE exhibited increased expression of β-catenin
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Figure 3 CSCM is induced in limbal and peripheral cells during repair.
(a) Immunofluorescent staining for K12 and K1 in WT (Notch1lox/lox )
and Notch11 corneas at 0, 6 and 24h after a second corneal injury.
The images are representative of 6 corneas per genotype over two
independent experiments for each time point analysed. Large panels
are low-magnification tiled images. Insets outlined in green, red and
yellow show high-magnification images of the limbus, peripheral cornea
and central cornea, respectively. (b) XY scatter plots showing K12
and K1 expression in the limbus, peripheral cornea and central cornea
24h after a second corneal injury. Each data point represents mean
fluorescence intensity measured from an individual cornea. Grey squares,
WT (Notch1lox/lox ); black squares, Notch11 (n=6 corneas for each genotype
over three independent experiments). (c) Model predicting the cellular
origin of CSCM. Following injury to the central cornea, stem/progenitor
cells in the peripheral cornea become activated and proliferate to generate
daughter cells that mediate wound closure. In Notch11 mutants, chronic
inflammation promotes epidermal differentiation of activated stem/progenitor
cells or their immediate progeny. This model therefore predicts that all
epidermal lineage cells in Notch11 corneas will be derived from peripheral
stem/progenitor cells and therefore be continuous with the peripheral
cornea. (d) Immunofluorescent staining for K12 and K1 on whole-mount
corneal epithelial tissue from WT (Notch1lox/lox ) and Notch11 mice after
repeated injury. The images are representative of 12 corneal whole-mounts
per genotype over four independent experiments. Images shown are low-
magnification tiled images. Scale bars represent 500 µm on tiled images and
5 µm on all other images.
following induction of CSCM by repeated injury (Fig. 4a). To
determine whether increased β-catenin expression overlapped
with CSCM induction, we quantified its expression during each
injury–repair cycle. In unwounded corneas and during the first
injury–repair cycle, β-catenin expression was relatively high in the
limbus but declined in the peripheral and central CE in WT and
Notch11 mice (Supplementary Fig. 4a,b). However, following the
second injury, high β-catenin expression was evident throughout
the Notch11 CE (Fig. 4b,c). In WT controls, β-catenin expression
was increased in the limbus, but again declined in the peripheral
and central CE (Fig. 4b,c). Thus, high β-catenin expression
overlapped spatially and temporally with the presence of K12−K1+
epidermal cells.
To definitively establish whether β-catenin is the molecular
factor that induces CSCM, we performed loss- and gain-of-
function experiments in vivo. Thus, to determine whether
β-catenin is necessary for CSCM induction, tamoxifen-treated
Notch1lox/lox :Ctnnb1lox/lox :K5CreERT mice, in whichNotch1 andCtnnb1
(β-catenin) are simultaneously ablated in the CE (Notch11:Ctnnb11),
were subjected to repeated corneal injury (Fig. 4d). This resulted
in chronic inflammation in the corneal stroma in a similar manner
to Notch11 mutants (Fig. 4e). However, β-catenin-deficient cells
172
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Figure 4 Chronic inflammation promotes CSCM through elevated β-catenin
signalling. (a) Immunohistochemistry for β-catenin on WT (Notchlox/lox ) and
Notch11 corneas after repeated injury. Data are representative of 8 corneas
per genotype over three independent experiments. (b) Immunofluorescent
staining for β-catenin in limbus, peripheral cornea (Per.) and central cornea
(Cen.) of WT (Notchlox/lox ) and Notch11 corneas 24 h after the second
corneal injury. The images are representative of 6 corneas isolated over three
independent experiments. (c) Quantification of relative β-catenin expression
in limbus, peripheral cornea and central cornea 24h after the second corneal
injury. Black bars, WT (Notch1lox/lox ); grey bars, Notch11 (n=6 corneas for
each genotype over three independent experiments). Values for expression
levels are relative values normalized to the expression level in the conjunctiva
of each sample, determined by mean fluorescence intensity. (d) Schematic
depiction of the experimental strategy used to determine whether β-catenin
is necessary for the induction of CSCM. (e) Immunofluorescent staining
for K12, K1 and CD45 on Notch11 and Notch11:Ctnnb11 corneas after
the procedure outlined in d. The images are representative of 8 corneas
per genotype over three independent experiments. Large panels are low-
magnification tiled images. Insets are high-magnification images of the
indicated regions. (f) Schematic depiction of the experimental strategy
used to determine whether elevated β-catenin is sufficient to induce
CSCM. (g) Immunofluorescent staining for K12, K1 and CD45 on WT
(Ctnnb1lox(ex3)/lox(ex3)) and Ctnnb11Ex3 corneas 7 days after a single corneal
injury. The images are representative of 8 WT corneas and 10 Ctnnb11Ex3
corneas over four independent experiments. Large panels are low magnifi-
cation tiled images. White outlined insets are high-magnification images of
the indicated regions. Scale bars represent 500 µm on tiled images and 5 µm
on all other images. White dotted lines indicate the boundary between the
stroma and epithelium. St, stroma; NS, not significant. ∗P<0.01, ∗∗P<0.05
(unpaired, two-tailed t-tests). Error bars represent standard deviation.
retained a predominantly K12+K1− phenotype, even in the presence
of a chronic inflammatory environment, although the epithelium
remained hyperplastic (Fig. 4e, Supplementary Fig. 4c). Thus,
elevated β-catenin signalling in corneal epithelial cells is essential for
inflammation-induced CSCM.
In the reciprocal gain-of-function experiment, we induced
constitutive activation of β-catenin in the CE using tamoxifen-
treated Ctnnb1lox(ex3)/lox(ex3):K5CreERT mice44 (hereafter referred to
as Ctnnb11Ex3 mice), in which β-catenin is stabilized owing to cre-
mediated excision of the degradation domain within exon 3. After a
single injury–repair cycle (Fig. 4f), Ctnnb11Ex3 mice exhibited epider-
mal differentiation on the ocular surface, in contrast to WT controls
that, as expected, maintained a corneal phenotype (Fig. 4g). In this
system, there was no evidence of chronic inflammation, as the pres-
ence of CD45+ cells in the Ctnnb11Ex3 stroma seemed equivalent to
WT controls (Fig. 4g). Furthermore, the induction of epidermal differ-
entiation correlated strictly with elevated β-catenin expression (Sup-
plementary Fig. 4d). Together, these data strongly suggest that overex-
pression of β-catenin is sufficient for the cell-autonomous induction of
CSCM. In addition, whole-mount immunofluorescence demonstrated
that regions of CSCM in Ctnnb11Ex3 cornea remained continuous
with the limbus/peripheral cornea (Supplementary Fig. 4e), thus
supporting the hypothesis that CSCM is induced at this location.
Chronic inflammation is associated with excessive ECM
deposition, increased tissue stiffness and elevated
mechanotransduction in the CE
We next addressed the mechanism by which chronic inflammation
elicits elevated β-catenin in the CE. Surprisingly, we could not
find any evidence of increased Wnt ligand expression in the
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Figure 5 Increased ECM deposition in the corneal stroma in response
to aberrant inflammation. (a) Immunofluorescent staining for K14 and
tenascin C (TenC) in WT (Notch1lox/lox ) and Notch11 corneas, unwounded
and 24h after first and second wounds. The images are representative of
6 corneas per genotype for each time point analysed over three independent
experiments. (b) Relative quantification of tenascin C expression in the limbus
(Limb.), peripheral cornea (Per.) and central cornea (Cen.). Upper panel
shows uninjured cornea; middle panel shows corneal tissue 24h after the
first injury; lower panel show corneal tissue 24h after the second injury.
Values for expression levels are relative values normalized to the expression
level in the conjunctival stroma of each sample, determined by mean
fluorescence intensity. Black bars, WT (Notch1lox/lox ); grey bars, Notch11
(n=6 corneas for each genotype at each time point over three independent
experiments). (c) Immunofluorescent staining for K14 and periostin (POSTN)
in WT (Notch1lox/lox ) and Notch11 corneas. The images are representative of
6 corneas per genotype for each time point analysed over three independent
experiments. (d) Relative quantification of periostin expression in the limbus,
peripheral cornea and central cornea in uninjured tissue (upper panel),
corneal tissue 24h after the first injury (middle panel) and corneal tissue
24h after the second injury (lower panel). Values for expression levels are
relative values normalized to the expression level in the conjunctival stroma
of each sample, determined by mean fluorescence intensity. n=6 corneas
for each genotype at each time point over three independent experiments.
Scale bars on tiled images represent 500 µm. NS, not significant.
∗P<0.01, ∗∗P < 0.05 (unpaired, two-tailed t-tests). Error bars represent
standard deviation.
Notch11 cornea (Supplementary Fig. 5a), suggesting that the chronic
inflammatory environment does not activate the Wnt signalling
cascade. Previous studies have linked mechanotransduction to the
induction of β-catenin activity in epithelia15. The mechanisms
underlying mechanotransduction remain to be fully elucidated,
although YAP/TAZ have recently emerged as primary cellular sensors
of tissue mechanical cues14,45. Intriguingly, a recent report has shown
that YAP/TAZ directly regulate β-catenin expression by forming
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an integral part of the cytoplasmic β-catenin destruction complex.
According to the proposed model, removal of YAP/TAZ from
the destruction complex, through mechanically induced nuclear
translocation, increases β-catenin expression owing to impaired
degradation46. We therefore speculated that chronic inflammation
may induce aberrant mechanotransduction in the CE by causing
changes in the mechanical properties of the corneal stroma, for
example through excessive deposition of ECM, as occurs in fibrosis47.
This would therefore result in nuclear localization of YAP/TAZ and
increased β-catenin expression.
To determine whether increased ECM deposition was associated
with CSCM, the expression of the ECM proteins periostin and
tenascin C, which are linked to fibrosis48,49, was analysed during
each injury–repair cycle. In WT corneas, both periostin and tenascin
C were restricted to the stroma underlying the limbus at each
stage (Fig. 5a–d). A similar pattern was observed in unwounded
Notch11 corneas and in Notch11 corneas during the first injury–
repair cycle (Fig. 5a–d). However, expression in the peripheral
and central corneal stroma of Notch11 mutants increased markedly
during the second injury–repair cycle (Fig. 5a–d). In support of a
fibrotic-like response, the expression of periostin and tenascin C was
largely restricted to non-haematopoietic cell types (Supplementary
Fig. 5b). Furthermore, abrogation of inflammation inNotch11mice by
Tobradex treatment resulted in reducedECMdeposition in the corneal
stroma (Supplementary Fig. 5c), indicating that the effect occurred
downstream of inflammation.
ECM deposition in the corneal stroma also correlated with
activation of mechanotransduction in the overlying CE after the
second injury, as demonstrated by increased phosphorylation of
focal adhesion kinase (pFAK), and increased nuclear localization
of Rho coiled-coil kinase 2 (ROCK2) and YAP/TAZ (Fig. 6a–g).
Importantly, in unwounded corneas and in corneas isolated after
the first injury, mechanotransduction was restricted to the ECM-
rich limbus and was not apparent in the CE (Supplementary
Fig. 6a,b). Furthermore, abrogation of inflammation in Notch11
mice by Tobradex treatment reduced mechanotransduction in the
corneal epithelium (Supplementary Fig. 6c). Thus, in a similar
manner to β-catenin, there was a spatial and temporal overlap
between increased ECM deposition, mechanotransduction and
CSCM induction.
To gather additional evidence of a role for mechanotransduction,
we determined whether ECM deposition resulted in changes in the
mechanical properties of the corneal stroma by employing atomic
force microscopy in combination with immunofluorescence. This
enabled us to correlate the expression of ECMwith tissue stiffness and
revealed that increased expression of tenascin C in Notch11 corneas
correlated with increased stiffness of the corneal stroma compared
withWT controls, an effect that was apparent at the limbus, peripheral
CE and central CE (Fig. 7a,b).
In light of the above data, we sought to establish a functional
link between mechanotransduction and β-catenin signalling. We
therefore obtained primary cultures of pig corneal epithelial stem cells
(PCESCs), which can be readily cultivated in vitro, and determined
the effect of mechanical stimuli by growing these cells on stiff
versus soft substrates. Importantly, in this assay, PCESCs were
cultured in the absence of feeder cells to promote differentiation.
Strikingly, cells grown on stiff substrates expressed higher levels
of β-catenin compared with cells grown on soft substrates, as
well as exhibiting increased nuclear localization of YAP/TAZ and
perturbed differentiation (Fig. 7c–g). Moreover, PCESCs cultured on
extremely stiff substrates (glass) in the presence of the ROCK inhibitor
Y27632 expressed lower levels of β-catenin, exhibited reduced nuclear
localization of YAP/TAZ and exhibited a higher propensity for
corneal differentiation compared with cells maintained in vehicle
(Supplementary Fig. 7a–e).
Further evidence of a link between mechanotransduction and
β-catenin signalling was provided by induction of TCF–luciferase
activity in reporter cells following expression of a constitutively active
ROCK2 kinase domain (Supplementary Fig. 7f–h), indicating that
forced activation of the mechanotransduction cascade does indeed
activate β-catenin signalling.
Collectively, these data support the hypothesis that activation
of mechanotransduction is sufficient to promote elevated β-catenin
activity in corneal epithelial cells and, in addition, suggest that this is
a mechanism that is conserved across species.
Modulation of mechanotransduction cascades regulates cell
fate on the ocular surface
To definitively establish that chronic inflammation promotes CSCM
throughmechanotransduction, we testedwhethermanipulation of the
mechanotransduction cascade affects cell fate on the ocular surface
in vivo. In the first instance, we determined whether inhibition
of mechanotransduction could restore corneal differentiation in
chronically inflamed Notch11 corneas by using small-molecule
inhibitors of FAK (PF562271) or ROCK (Y27632; Fig. 8a). Strikingly,
mice treated with either inhibitor retained a predominantly K12+K1−
CE, despite the presence of a chronically inflamed stroma (Fig. 8b–e),
thus supporting the hypothesis that chronic inflammation elicits
CSCM through activation of mechanotransduction.
To test the hypothesis further, we performed the reciprocal exper-
iment by ablating YAP/TAZ from the CE, thus removing cytoplasmic
YAP/TAZ and recapitulating the effect ofmechanotransduction. Thus,
tamoxifen-treated Yaplox/lox :Taz lox/lox :K14CreER mice, in which YAP
and TAZ are ablated in the CE (YAP1:TAZ1), were subjected to a
single corneal injury and analysed 7 days later (Fig. 8f). Strikingly,
the ocular surface of YAP1:TAZ1 corneas exhibited overt epidermal
differentiation, particularly in peripheral regions (Fig. 8g), which
correlated with loss of YAP/TAZ (Fig. 8h) and increased β-catenin
expression (Fig. 8i). As expected, WT controls maintained corneal
identity throughout the CE (Fig. 8g–i).
Collectively, these data provide functional evidence that
chronic inflammation induces CSCM by activating the mechano-
transduction cascade.
DISCUSSION
In this study we have demonstrated that a central mechanism by
which chronic inflammation can promote aberrant cell fate is through
mechanotransduction (Fig. 8j). The data presented support a model
whereby exposure of the corneal stroma to chronic inflammation
results in the induction of excessive ECM deposition, which
subsequently promotes epidermal differentiation in the regenerating
epithelium through mechanical induction of β-catenin signalling.
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Figure 6 Activation of mechanotransduction in the corneal epithelium
in response to aberrant inflammation. (a) Schematic depiction of key
molecular mediators and/or sensors of mechanotransduction in epithelial
cells. (b–d) Immunofluorescent staining for pFAK (b), ROCK2 (c) and
YAP/TAZ (d) in the limbus, peripheral cornea and central cornea of WT
(Notch1lox/lox ) and Notch11 mice 24h after the second corneal injury. In d
images without DAPI are shown to enable clearer visualization of nuclear
YAP/TAZ. The images are representative of 6 corneas per genotype over three
independent experiments. (e) Quantification of FAK phosphorylation in the
limbus, peripheral cornea and central cornea 24h after the second injury.
Values for expression levels are relative values normalized to the expression
level in the conjunctiva of each sample, determined by mean fluorescence
intensity. Black bars, WT (Notch1lox/lox ); grey bars, Notch11 (n=6 corneas
for each genotype over three independent experiments). (f,g) Quantification
of nuclear/cytoplasmic ratio (N/C) of ROCK2 (f) and YAP/TAZ (g) in the limbus,
peripheral cornea and central cornea 24h after the second injury. n= 6
corneas for each genotype over three independent experiments. St, stroma;
NS, not significant. ∗P<0.01, ∗∗P<0.05 (unpaired, two-tailed t-tests). Error
bars represent standard deviation. Scale bars represent 5 µm. White dotted
lines indicate the boundary between the stroma and epithelium.
Themechanisms underlying ECMdeposition in this model remain
to be fully elucidated, although the expression of matrix components
is confined to non-haematopoietic stromal cells, thus suggesting that
the changes in the ECM occur owing to a fibrotic-like process. A
variety of immune cells, including macrophages50, neutrophils51 and
T cells52, are linked to the induction of fibrosis through the secretion
of cytokines such as TGF-β (refs 53,54) and IL-13 (refs 22,55),
which subsequently induce excessive ECM deposition by α-SMA+
myofibroblasts56–58. It will thus be interesting to determine whether
similar cellular andmolecular mechanisms are involved in the stromal
remodelling observed in the chronically inflamed cornea. The profiles
of inflammatory cell types in the corneal stroma of both WT and
Notch11 mice are similar following injury and consist predominantly
of CD11b+Gr1+ neutrophils, although the magnitude of the response
is elevated in Notch11 mice. However, the prolonged duration of the
inflammatory response in Notch1 mutants seems to be critical for the
induction of stromal remodelling and resulting metaplasia, as both
of these effects occur following repeated cycles of injury and repair.
Experiments in which specific inflammatory cell types and cytokines
can be efficiently depleted will enable delineation of the specific
cellular andmolecularmediators involved andmay identify promising
targets for therapeutic intervention in ocular surface disorders.
The induction of CSCM in the model described here is initially
induced in the limbus and peripheral corneal epithelium, locations
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Figure 7 CSCM is associated with increased tissue stiffness and mechanical
stimuli. (a) Immunofluorescence for K14 and tenascin C (upper panels)
and corresponding atomic force microscopy (AFM) nanomechanical property
measurement (lower panels) of limbus, peripheral cornea and central cornea
after repeated injury. The elastic modulus was determined using AFM force–
volume mode. Data are representative of 4 corneas per genotype over 4
independent experiments. (b) Quantification of the elastic modulus (kPa) of
stromal tissue from the limbus (left), peripheral cornea (middle) and central
cornea (right) of the regions shown in a. Red lines in each box represent
the median elastic modulus value of 256 force–volume measurements in
the regions shown in a. Red lines in each whisker represent outliers.
Boxes represent the middle 50% of the data. (c,d) Immunofluorescence
for β-catenin, K12 and K1 (c) or YAP/TAZ, K12 and K1 (d) on PCESCs
cultured on soft (upper panels) or stiff (lower panels) substrates. Data are
representative of 6 individual cultures over 2 independent experiments.
(e–g) Quantification of β-catenin expression (MFI, mean fluorescence
intensity) (e), YAP/TAZ nuclear/cytoplasmic ratio (N/C) (f) and the proportion
of K12+K1− and K12−K1+ cells (g) in PCESCs cultured on soft or stiff
substrates (n=6 for each condition over 2 independent experiments, where
one replicate represents quantification from a single culture). For e, β-catenin
expression is determined by mean fluorescence intensity. Scale bars in a
represent 15 µm; scale bars in c and d represent 20 µm. ∗P<0.01, ∗∗∗P<0.1
(unpaired, two-tailed t-tests). Error bars represent standard deviation (e–g) or
maximal values/1.5× interquartile range (b).
that contain significant numbers of activated stem/progenitor cells
following injury. In addition, it is notable that although there is a
significant overlap between elevated β-catenin expression and CSCM,
not all β-cateninhi cells undergo epidermal fate conversion. This
therefore suggests that only a proportion of epithelial cells on the
anterior ocular surface are permissive to β-catenin-induced fate
switching. Given that the induction of CSCM coincides temporally
and spatially with the activation of stem/progenitor cells in the limbus
and peripheral cornea, it is tempting to speculate that these cells
represent uncommitted progenitor cells that retain the potency to
form epidermis in response to elevated β-catenin. To formally prove
this hypothesis, phenotypic markers that precisely identify stem and
progenitor cells in the corneal epithelium are required to definitively
establish the cellular target of β-catenin-induced CSCM.
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Figure 8 Manipulation of mechanotransduction affects corneal cell
fate. (a) Schematic depiction of the experimental strategy used to
determine whether inhibition of mechanotransduction prevents CSCM.
(b) Immunofluorescent staining for K12, K1 and CD45 on Notch11 corneas
treated with vehicle (dimethylsulphoxide, DMSO) or the FAK inhibitor
PF562271 during the procedure outlined in a. The images are representative
of 8 corneas per treatment over four independent experiments. Large panels
are low-magnification tiled images. Insets show high-magnification images
of the indicated regions. (c) Quantification of the proportion of Notch11
corneas exhibiting corneal or epidermal differentiation during wound closure
following treatment with vehicle or PF562271 (n= 8 corneas for each
treatment over four independent experiments). (d) Immunofluorescent
staining for K12, K1 and CD45 on Notch11 corneas treated with vehicle
(PBS) or the ROCK inhibitor Y27632 after the procedure outlined in a. The
images are representative of 10 corneas per treatment over four independent
experiments. Large panels are low-magnification tiled images. Insets show
high-magnification images of the indicated regions. (e) Quantification of the
proportion of Notch11 corneas exhibiting corneal or epidermal differentiation
during wound closure following treatment with vehicle or Y27632 (n=10
corneas for each treatment over four independent experiments). (f) Schematic
depiction of the experimental strategy used to determine whether ablation of
YAP/TAZ is sufficient to induce CSCM during repair. (g) Immunofluorescent
staining for K12, K1 and CD45 on WT (Yap+/+:Taz+/+:K14CreER) and
YAP1:TAZ1 corneas after the procedure outlined in f. The images are
representative of 6 corneas for WT and 7 corneas for YAP1:TAZ1 isolated
over two independent experiments. Large panels are low-magnification
tiled images. Insets show high-magnification images of the indicated
regions. (h,i) Immunofluorescent staining for YAP/TAZ, K12 and K1 (h) and
β-catenin, K12 and K1 (i) in WT and YAP1:TAZ1 corneas as indicated.
The images are representative of 6 corneas for WT and 7 corneas for
YAP1:TAZ1 isolated over two independent experiments. (j) Model depicting
how chronic inflammation imposes aberrant cell fate on corneal epithelial
stem cells through increased tissue stiffness and mechanotransduction.
Scale bars represent 500 µm on tiled images and 5 µm on all other
images. St, stroma. White dotted lines indicate the boundary between the
stroma and epithelium.
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Finally, although this study demonstrates that mechanotransduc-
tion is a key mechanism by which chronic inflammation can impose
aberrant cell fate, the mechanisms by which inflammation influ-
ences other aspects of stem/progenitor cell function are likely to be
multifaceted. Notably, although inhibition of mechanotransduction
and/or β-catenin signalling restores corneal identity in a chronic in-
flammatory environment, the epithelium remains hyperplastic. Thus,
inflammation is likely to effect traits such as cell fate and proliferation
through distinct mechanisms.
In summary, our findings demonstrate that chronic inflammation
can promote aberrant cell fate through mechanotransduction and
thus reveal an important mechanism by which aberrant inflammatory
responses can promote the development of disease. 
METHODS
Methods and any associated references are available in the online
version of the paper.
Note: Supplementary Information is available in the online version of the paper
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METHODS
Ethics statement.All animal work was conducted in accordance with Swiss national
guidelines. All mice were kept in the animal facility under EPFL animal care
regulations. They were housed in individual cages at 23 ◦C ± 1 ◦C with a 12 h
light/dark cycle. All animalswere suppliedwith food andwater ad libitum. This study
has been reviewed and approved by the Service Veterinaire Cantonal of Etat de Vaud.
Mice. Notch1lox/lox , Ctnnb1lox/lox and K5CreERT mice were as previously described59–61
and were maintained on a C57BL/6 background. cjunlox/lox mice were as previously
described62 and were provided by E.F.W. Yaplox/lox :Taz lox/lox :K14CreER were as
previously described5 provided by S.P. These mice were backcrossed onto the
C57BL/6 background. Ctnnb1lox(ex3) and K14TSLPTg mice were as previously
described6,7 and were maintained on an sv129 background. The conditional
mutant strains Notch1lox/lox :K5CreERT , Notch1lox/lox :Ctnnb1lox/lox :K5CreERT ,
Notch1lox/lox :cjunlox/lox :K5CreERT and Ctnnb1lox(ex3)/lox(ex3) were generated by
performing the required inter-crosses and were maintained as homozygotes.
For conditional ablation of YAP/TAZ, Yaplox/lox :Taz lox/lox :K14CreER mice were
administered with 1mg tamoxifen once a day for 3 days by intraperitoneal injection.
For all other gene activation/inactivation experiments, tamoxifen dissolved in
peanut oil was administered once a day for 5 consecutive days by intraperitoneal
injection at a dose of 50mg kg−1. For each experiment, all mice were age matched
and were between 4 and 7weeks of age. Male and female animals were used. All
mouse experiments were non-randomized and non-blinded; a minimum of three
animals were used for each experiment, allowing a minimum of six corneas to be
analysed for each experiment. This number was deemed sufficiently appropriate
to account for normal variation, as determined from previous studies. Numbers
of animals for each experiment are described in the figure legends. No statistical
method was used to predetermine sample size.
Statistical analysis. For statistical analysis, unpaired two-tailed t-tests were
performed on normally distributed data sets with equal variance assumed. Unless
otherwise stated, n numbers for experiments stating statistical significance represent
biological replicates. Sample size in all cases was a minimum of 6 independent
biological replicates, according to availability of biological material.
Corneal wounding. Mice were anaesthetized by sub-cutaneous injection of
ketamine (100mg kg−1) and xylazine (10mg kg−1). Anaesthetic collrium (0.4%
oxybuprocaine) was applied to the ocular surface to prevent corneal reflex.
To wound the ocular surface, a circular area 2mm in diameter was marked on
the central cornea by gentle application of a 2mm biopsy punch. Removal of the
epithelial tissue within this area was then achieved using a Demarres spatula (Moria
Surgical) with a 45◦ cutting angle. The efficiency of wounding was monitored by
application of 0.5% solution of ophthalmic fluorescein (Novartis). Following corneal
wounding, Viscotears ophthalmic gel (Novartis) was applied to the ocular surface.
On waking, mice were administered with 0.3ml 0.9% NaCl solution (Braun)
to aid recovery. Dafalgen analgesic was provided in the drinking water following
corneal wounding at a concentration of 2mgml−1.
Administration of Tobradex anti-inflammatory gel. Tobradex gel or ophthalmic
lubricating gel was administered topically to the ocular surface once a day
throughout the corneal wounding procedure, starting from the day of the first
corneal wound and ending 21 days after the third corneal wound.
Administration of PF562271 (FAK inhibitor) and Y27632 (ROCK inhibitor).
For systemic administration, PF562271 (Selleckchem) was dissolved in 70%
DMSO/dH2O and injected i.p. at a dose of 30mg kg−1 every other day for 14 days
following the final corneal injury. Control mice were injected with 70% DMSO
vehicle alone. For topical application, a 3 µl drop of 10mM PF562271 was applied
to the ocular surface twice a day for 14 days following the final corneal injury in a
15% DMSO solution (diluted in dH20). Control mice were administered with 15%
DMSO vehicle alone.
For systemic administration, Y27632 (Sigma) was dissolved in saline solution
and injected i.p. at a dose of 30mg kg−1 every other day for 14 days following the
final corneal injury. Control mice were injected with saline vehicle alone.
For topical application, a 3 µl drop of 10mMY27632 diluted in salinewas applied
to the ocular surface twice a day for 14 days following the final corneal injury. Control
mice were administered with saline vehicle alone.
Cell culture. Peripheral corneal epithelial cells were isolated from porcine corneas
and cultivated on lethally irradiated 3T3-J2 feeder cells in 3:1 DMEM/F12 medium
supplemented as previously described63.
For experiments analysing the effect of substrate stiffness, cells were plated on
glass coverslips, standard tissue culture plastic, 15% PEG or 2.5% PEG hydrogels in
the absence of 3T3-J2 feeders at a density of 50,000 cells cm−2. For experiments using
the ROCK inhibitor Y27632, cells were seeded onto glass coverslips in the absence of
3T3-J2 feeders at a density of 50,000 cells cm−2. All substrates in feeder-free cultures
were coated with recombinant human collagen I (AteloCell). Glass coverslips were
treated with poly-L-lysine (Sigma) before collagen coating.
Hydrogel substrates were formed by crosslinking two branched PEG precursors
of relative molecular mass 10,000, end-functionalized with either thiol (TH) or
vinylsulphone (VS) groups (NOFCorporation). To adjust the stiffness the precursors
were mixed at different mass to volume ratios. Fifty microlitres of the mixed
hydrogel precursor solution were transferred to each well of a 12-well plate (Falcon).
A hydrophobic PDMS stamp with spacers was used to produce homogeneous
and thin gel layers. The partially crosslinked hydrogel substrate was subsequently
functionalizedwithCollagen I (AteloCell) under pressure for 2 h. The functionalized
hydrogel layers were then washed with PBS and ultraviolet-sterilized.
Transient transfection of porcine corneal epithelial cells was performed using
JetPEI transfection reagent (PolyPlus) according to the manufacturer’s instructions.
TCF–Luc 293T cells were maintained in DMEM supplemented with 10% FCS.
TCF–luciferase reporter assay. 293T cells with a stably integrated luciferase cassette
containing upstream TCF-binding sites were a kind gift from J. Huelsken. To assay
TCF–luciferase activity in the presence or absence of the murine ROCK2 kinase
domain, TCF–Luc 293T cells were transiently co-transfected with pR2KD/pRenilla
or pEGFP/pRenilla using JetPEI (PolyPlus) transfection reagent according to the
manufacturer’s instructions. Luciferase activity was subsequently analysed 36–48 h
later using the Dual-Luciferase Reporter Assay System (Promega) and a Berthold
Lumat Luminometer. Luciferase values were normalized toRenilla–luciferase values.
Preparation of corneal single-cell suspensions and flow cytometry. Whole
corneal tissue was isolated from murine eyes, placed in ice-cold PBS and
cut into small fragments using a scalpel blade. Corneal fragments were then
digested in 2mgml−1 collagenase IV (Invitrogen)/PBS for 30–45min at 37 ◦C
with gentle shaking. The resulting cell suspensions were then passed through
a 70 µm cell strainer into 1× HBSS/25mM HEPES/2% newborn bovine calf
serum (staining medium). Cells were subsequently washed twice with staining
medium and then stained according to standard flow cytometry protocols with
the following monoclonal antibody conjugates: anti-CD45–Pacific blue (clone
30-F11, Invitrogen), anti-CD11b–PE (clone M1/70, Biolegend), anti-Gr-1–Alexa
647 (clone RB6-8C5, EPFL Protein Core Facility), anti-CD11c–APC–eFluor 780
(clone N418, eBiosciences), anti-B220–PECy7 (clone RA3-6B2, eBiosciences), anti-
TCRB–APC–eFluor 780 (cloneH57-597, eBiosciences), anti-CD4–PE (cloneGK1.5,
EPFL Protein Core Facility), anti-CD8–Alexa Fluor 647 (clone YTS169.4, EPFL
Protein Core Facility), anti-F4/80–biotin (clone BM8, eBiosciences), Streptavidin–
FITC (eBiosciences). Before analysis, propidium iodide (Sigma) was added to cell
suspensions at a final concentration of 5 µgml−1 to enable dead cell exclusion. Data
acquisition was performed using a Cyan flow cytometer (Dako) and analysed using
FlowJo software (Tree Star).
Molecular cloning and generation of the pR2KD plasmid. cDNA synthesis was
performed using the Quantitect Reverse Transcription kit (Qiagen) on RNA isolated
from mouse corneal tissue. The region of cDNA encompassing the first 417 amino
acids of the amino-terminal kinase domain was subsequently PCR cloned in two
fragments; a 641 bp 5′ fragment starting 12 bp upstream of the initiating ATG
and a 659 bp 3′ fragment starting 591 bp downstream of the initiating ATG. A
38 bp overlapping region was present in each fragment. The primers used to
generate each fragment were as follows: 5′ fragment: Fwd 5′-AATTGTCCAGA
ATTCGGCGAAGCGGCATGAGC-3 ′; Rev 5 ′ -TAAGCCCATGGAGTGTA
TTGC-3 ′; 3′ fragment: Fwd 5 ′ -GTAGTGCTTGCACTGGATGC-3 ′; Rev 5′-
CTACTACTATCTAAAGTAGGTAAATCCTATAAAAGGCAGC-3′.
The above primers enabled the incorporation of a 5′ SalI site (bold
underlined) and ×3 3′ STOP codons (bold double underlined) in the 5′ and 3′
fragments respectively.
Cycling conditions were as follows: 5′ fragment ×35 cycles of 94 ◦C, 30 s: 62 ◦C
30 s: 72 ◦C 30 s; 3′ fragment×35 cycles of 94 ◦C, 30 s: 60 ◦C 30 s: 720C 30 s.
PCR was performed using Q5 DNA polymerase (NEB) according to the man-
ufacturer’s instructions, with the addition of DMSO to a final concentration of 5%.
Amplified fragments were cloned using the TOPO TA cloning system (Invitrogen).
The 5′ and 3′ fragments were inserted into an expression vector (pI-EGFP2)
downstream of a CMV promoter/enhancer and upstream of an IRESEGFP cassette
through a three-way ligation using SalI, NcoI (present in the overlapping region of
each fragment) and Not-I restriction sites, resulting in the generation of pR2KD.
Tissue processing for histology. Fresh frozen and paraffin-embedded tissues were
used for histological analysis. For fresh frozen tissue, whole eyes were embedded in
OCT compound (TissueTek) using standard protocols. Eight-micrometre-thick sec-
tions were cut using a Leica CM1850 cryostat. Cryosections were stored at−80 ◦C.
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For paraffin-embedded tissue, whole eyes were fixed in 4% PFA overnight at
4 ◦C. Fixed tissue was then processed using standard protocols and embedded in
paraffin wax. Four-micrometre-thick sections were cut using a Thermo Scientific
Microm HM325 microtome. Sectioned tissue was dried at 37 ◦C overnight and then
stored at 4 ◦C.
Immunofluorescence using fresh frozen tissue. For immunofluorescence on
fresh frozen tissue, cryosections were fixed in ice-cold acetone for 2min and
then air dried for 20min at room temperature. Sections were then rinsed in PBS
and incubated in 1%BSA/PBS/0.1% Tween20 for 30min at room temperature to
block nonspecific antibody binding. Primary antibody solutions diluted in PBS
were then added at the appropriate dilution and incubated overnight at 4 ◦C
or for 1 h at room temperature. The antibodies used and their dilutions were:
anti-keratin 14 (rabbit polyclonal, Covance (PRB-155P-100), 1:500), anti-keratin
1 (rabbit polyclonal, Covance (AF 109), 1:500), anti-keratin 12 (goat polyclonal,
Santa Cruz (sc-17101), 1:400), anti-ROCK2 (rabbit polyclonal, Abcam (ab71598),
1:100), anti-ROCK1 (rabbit IgG (EP786Y), Abcam, 1:100), anti-CD45 (rat IgG2b
(30-F11), BDBiosciences, 1:200), anti-β-catenin (mouse IgG1 (14/beta-catenin), BD
Biosciences, 1:50), anti-c-jun-phospho-S73 (rabbit polyclonal, Abcam (ab30620),
1:400), anti-FAK phospho-Y397 (rabbit polyclonal, Abcam (ab4803), 1:50), anti-
periostin (mouse IgG (IC12), a gift from J. Huelesken, 1:1,000), anti-tenascin C (rat
IgG1 (Mtn-12), Abcam, 1:400), anti-Ki67 (rabbit IgG (SP6), Abcam, 1:500).
Primary antibody solutions were then removed and sections were washed for
3×5min in PBS/0.1% Tween 20. Sections were then incubated in the appropriate
secondary antibody solutions diluted in PBS for 1 h at room temperature. The
antibodies used and their dilutions were: donkey-anti-rabbit Alexa Fluor 488
(Molecular Probes, 1:800), donkey-anti-mouse Alexa Fluor 568 (Molecular Probes,
1:800), goat-anti-rat Alexa Fluor 568 (Molecular Probes, 1:1,000), donkey-anti-goat
Alexa Fluor 568 (Molecular Probes, 1:600), donkey-anti-rabbit Alexa Fluor 647
(Invitrogen, 1:1,000), donkey-anti-rat Alexa Fluor 488 (Molecular Probes, 1:800),
Donkey-anti-goat Alexa Fluor 488 (Molecular Probes, 1:800). DAPI (Sigma) was
included in all secondary antibody solutions at a dilution of 1/4,000. Secondary
antibody solutions were then removed and sections were washed for 3× 5min in
PBS/0.1% Tween 20. A final rinse was performed in PBS and stained sections were
then mounted in DABCO (Sigma) anti-fade mounting medium.
Immunofluorescence using paraffin-embedded tissue. Paraffin-embedded tissue
sections were dewaxed and rehydrated and were then washed for 2 × 2min
in dH2O. Appropriate antigen retrieval was then performed depending on the
primary antibody combinations used (see below for antigen retrieval conditions).
Following antigen retrieval, sections were washed for 2× 2min in PBS at room
temperature and then blocked in 1%BSA/PBS/0.1% Tween20 for 30min at room
temperature. Primary antibody solutions diluted in 1%BSA/PBS/0.1% Tween20
were then added at the appropriate dilution and incubated overnight at 4 ◦C
or room temperature for 90min. The antibodies used and their dilutions were:
anti-keratin 1 (rabbit polyclonal, Covance (AF 109), 1:500), anti-keratin 12 (goat
polyclonal, Santa Cruz (sc-17101), 1:400), anti-β-catenin (mouse IgG1 (14/beta-
catenin), BD Biosciences, 1:50), anti-c-jun-phospho-S73 (rabbit polyclonal, Abcam
(ab30620), 1:400), anti-YAP/TAZ (mouse IgG2a (63.7), Santa Cruz, 1:200). Primary
antibody solutions were then removed and sections were washed for 3× 5min
in PBS/0.1% Tween20. Secondary antibody solutions diluted in 1%BSA/PBS/0.1%
Tween20 were then added at the appropriate dilution and incubated for 1 h at
room temperature. The antibodies used and their dilutions were: donkey-anti-
rabbit Alexa Fluor 488 (Molecular Probes, 1:800), donkey-anti-goat Alexa Fluor
568 (Molecular Probes, 1:600), donkey-anti-mouse Alexa Fluor 568 (Molecular
Probes, 1:800). Secondary antibody solutions were then removed and sections
were washed for 3× 5min in PBS/0.1% Tween20. A final rinse was performed
in PBS and stained sections were then mounted in DABCO (Sigma) anti-fade
mounting medium.
For YAP staining, a Mouse on Mouse blocking kit (Vectashield) was used and
staining was performed according to the manufacturer’s instructions.
Immunohistochemistry using paraffin-embedded tissue. For immunohistochem-
istry, antigen detection was performed using HRP-conjugated secondary antibodies
combined with DAB (Sigma) revelation. Primary antibodies were as described for
immunofluorescence. The staining procedure was as described for immunofluores-
cence with the addition of a peroxidase blocking step using 3%H2O2. The secondary
antibodies used were: donkey-anti-mouse IgG–HRP (Jackson, 1:100), goat-anti-
rabbit IgG–HRP (Jackson, 1:100).
Antigen retrieval for immunofluorescence/immunohistochemistry on
paraffin-embedded tissue. For detection of keratin 12, keratin 1, phosphoS73-cjun
and β-catenin, sections were incubated in 10mMTris/1mM EDTA/0.05% Tween20
(pH 9.0) for 20min at 95 ◦C.
For detection of Ki67, sections were incubated in 10mM sodium citrate/0.05%
Tween20 (pH 6.0) for 20min at 95 ◦C.
Immunocytochemistry. Cells were rinsed in PBS, fixed in 4% PFA for 15min at
room temperature and then washed twice with ice-cold PBS. Permeabilization was
performed by incubating the cells in PBS/0.25% Triton X-100 for 10min at room
temperature, followed by washing for 3×5min in PBS. Cells were then incubated
in 1%BSA/PBS/0.1% Tween20 for 30min at room temperature to block nonspecific
antibody binding. Primary antibody solutions diluted in 1%BSA/PBS/0.1%Tween20
were then added and cells were incubated overnight at 4 ◦C. The primary antibodies
used and their dilutions were: anti-actin (mouse IgG1 (ACTNO5 (C4)), Abcam,
1:20), anti-keratin 12 (guinea pig polyclonal (AP09545SU-N), Acris, 1:200), anti-
keratin 1 (rabbit polyclonal, Covance (AF 109), 1:500), anti-β-catenin (mouse
IgG1 (14/beta-catenin), BD Biosciences, 1:50), anti-YAP/TAZ (mouse IgG2a (63.7),
Santa Cruz, 1:200), anti-Pax6 (rabbit polyclonal, Covance (PRB-278P-100), 1:500),
anti-keratin 14 (rabbit polyclonal, Covance (PRB-155P-100), 1:500), anti-GFP
(goat polyclonal, Abcam (ab6673), 1:400). Primary antibodies were removed and
cells were washed for 3× 5min in PBS. Secondary antibody solutions diluted in
1%BSA/PBS/0.1% Tween20 were then added and cells were incubated for 1 h at
room temperature. The secondary antibodies used and their dilutions were: goat-
anti-mouse Alexa Fluor 488 (Molecular Probes, 1:1,000), donkey-anti-rabbit Alexa
Fluor 647 (Molecular Probes, 1:1,000), donkey-anti-guinea pig biotin (Jackson,
1:200). For keratin 12 staining, an additional incubation in streptavidin Alexa Fluor
568 (Molecular Probes, 1:800) was required following incubation in the secondary
antibody solutions. DAPI (Sigma) was included in all secondary antibody solutions.
Cells were washed for 3×5min in PBS and then mounted in DABCO (Sigma; when
cells were grown on coverslips) or stored in PBS.
Whole-mount immunofluorescence. Whole corneal tissue was dissected from
the surrounding eye tissue and then incubated in 20mM EDTA/PBS (pH 7.4) at
37 ◦C for 45min. The intact cornea was then placed epithelial side down onto
Superfrost Plus histology slides (Thermo Scientific) and air dried for 3–5min.
Stromal tissue was then removed using forceps, leaving the intact corneal epithelium
attached to the slide. The tissue was then fixed in ice-cold acetone for 2min and
then air dried for 20min at room temperature. Immunofluorescent staining was
performed using the protocols described for fresh frozen tissue.
Microscopy. Tiled images (fluorescent and bright-field) were acquired using a Leica
DM5500 microscope fitted with Leica DFC 320 and DFC 350FX cameras. Confocal
fluorescent images were acquired using a Zeiss LSM700 confocal microscope.
Bright-field images were acquired using an Olympus AX70microscope. Fluorescent
images for immunocytochemistry experiments were acquired using an Olympus
Cell XCELLENCE microscope fitted with a long-distance objective.
Image analysis. Quantification of β-catenin, K12, K1, pFAK, ROCK2, YAP/TAZ,
tenascin C and periostin was performed using ImageJ software. For in vivo analyses,
grid squares were used to specify regions corresponding to the limbus, peripheral
CE and central CE. Mean fluorescence intensity was then measured bilaterally on 5
sections per cornea. Values were normalized to the fluorescence intensity measured
in the conjunctiva of each section. For in vitro analyses, fluorescence intensity was
measured on a per cell basis in 5 fields for each replicate.
Protein extraction and western blotting. Protein was extracted from whole
cultured cells in RIPA buffer using standard protocols. Protein samples were
resolved by SDS–PAGE (8% acrylamide) and then blotted onto PVDF membranes
(Peqlab) by wet transfer using standard protocols. Unspecific interactions were
blocked by incubation in 5% milk (fat free) and then immunolabelling was
performed using the following primary antibodies: anti-ROCK2 (rabbit polyclonal,
Abcam (ab71598), 1:1,000), anti-actin (mouse IgG1 (ACTNO5 (C4)), Abcam,
1:2,000). Immunodetection was performed using the following HRP-conjugated
secondary antibodies: anti-mouse IgG (GEHealthcare, 1:1,000), anti-rabbit IgG (GE
Healthcare, 1:3,000). Revelation was performed using Pierce ECL Western Blotting
Substrate (Thermo Scientific).
Quantitative real-time RT–PCR. Corneal epithelium was isolated from the
underlying stroma by incubation in 20mM EDTA/PBS (pH 7.4) containing
RNA Later stabilization reagent for 45min at 37 ◦C. Separated, intact corneal
epithelium was then homogenized in Trizol reagent (Sigma) and total RNA was
isolated according to the manufacturer’s instructions and quantified using an ND-
100 NanoDrop spectrophotometer (NanoDrop Technologies). First-strand cDNA
synthesis was then performed using Quantitect reverse transcription kit (Qiagen).
Real-time PCR reactions were performed using SYBR Green and a 7900HT Real-
Time PCR System (both from Applied Biosystems) for 45 cycles. Specificity of the
reactions was determined by melting curve analysis. Relative quantification was
© 2016 Macmillan Publishers Limited. All rights reserved
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performed using the 2−DDCP method. α-tubulin was used as the reference gene.
Primer sequences were as follows: Notch1: Fwd 5′-CGCCCTTGCTCTGCCTA
ACG-3′, Rev 5′-TGCCACCATGGTCCACAACG-3′;Wnt1: Fwd 5′-ACAACAACG
AGGCAGGGCG-3′, Rev 5′-GGGGAGGGAGGCTTGTGC-3′;Wnt2: Fwd 5′-TGC
CAAGGAGAGGAAAGGC-3′, Rev 5′-TTCATGACTACCTGGATGGC-3′;Wnt3a:
Fwd 5′-AACCGTCACAACAATGAGGC-3′, Rev 5′-TTTCTCTACCACCATCTC
CG-3′;Wnt4: Fwd 5′-TTCACAACAACGAGGCTGGC-3′, Rev 5′-GGCTTGAACT
GTGCATTCCG-3′; Wnt7b: Fwd 5′-TCTGCAACAAGATTCCTGGC-3′, Rev 5′-G
CGACGAGAAAAGTCGATGC-3′; Wnt10a: Fwd 5′-TCGGAACAAAGTCCCCT
ACG-3′, Rev 5′-TCCGACGGAAACGTTCTTCG-3′; Wnt10b: Fwd 5′-ACAACAA
CAGGGTGGGACG-3′, Rev 5′-TGGAACGCTCCAGAGTTGC-3′; GM-CSF : Fwd
5′-CCTTGGAAGCATGTAGAGGC-3′, Rev 5′-ATATCTTCAGGCGGGTCTGC-
3′; IL-1β : Fwd 5′-CATTGTGGCTGTGGAGAAGC-3′, Rev 5′-TGTCCATTGAGG
TGGAGAGC-3′; S100A8: Fwd 5′-AACTGGAGAAGGCCTTGAGC-3′, Rev 5′-CC
ATCGCAAGGAACTCCTCG-3′; S100A9: Fwd 5′-CTTCTCAGATGGAGCGCAG
C-3′, Rev 5′-ATACACTCCTCAAAGCTCAGC-3′; IL-6 : Fwd 5′-CACATGTTCTC
TGGGAAATCG-3′, Rev 5′-TCTTCATGTACTCCAGGTAGC-3′; GCSF : Fwd 5′-A
AGTGCACTATGGTCAGGACG-3′, Rev 5′-ACTGTGGAGCTGGCTTAGGC-3′;
α-tubulin: Fwd 5′-TCGTAGACCTGGAACCCACG-3′, Rev 5′-GGTAAATGGAG
AACTCCAGC-3′.
Atomic force microscopy. Atomic force microscopy experiments were conducted
with a Dimension Icon AFM scanner (Bruker) mounted on a custom-built support
structure on top of an inverted optical microscope (IX71, Olympus). A 20-µm-
diameter bead (510-0166, VWR) was glued on the Lever D of a HYDRA-ALL-
G (AppNano) cantilever. The spring constant determined by the thermal noise
method64 was 0.12Nm−1 and the same cantilever was used for all experiments.
Force–volume measurements with 32 by 32 indentations over an area of 50 µm by
50 µm were taken at a rate of 1Hz to a maximum force of 11.5 nN.
The elastic modulus on the approach direction of force curves was calculated
assuming the Hertz contact model65. Subsequent analysis of elastic modulus maps
was done using Matlab.
Fluorescence images were taken with a 20× objective (LUCPanFLN 20X,
Olympus) and 2× magnifier in position with an iXon Ultra 897 (Andor) EMCCD
camera. Illumination was achieved with a halogen lamp (U-HGLGPS, Olympus)
and appropriate filter sets (MDF-GFP (Thorlabs) for K14–Alexa488, U-MNG2
(Olympus) for TenC–Alexa568, and F31-000 (AHFAnalysentechnikAG) forDAPI).
The relevant area was cropped and binned to a resolution of 32 by 32 pixels
using standard image processing software to match the resolution obtained by
AFM force–volume measurements. For wild-type samples, the image regions were
segmented into regions of epithelium and stroma by applying a threshold on
summedup intensity values from the fluorescent signals ofK14–Alexa488 andDAPI,
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Supplementary Figure 1 Inflammation in Notch1Δ mice following 
corneal injury. (a) Immunofluorescent staining for K12, K1 and CD45 in 
unwounded WT (Notch1lox/lox) and Notch1Δ corneas. Data are representative 
of 6 corneas over three independent experiments. (b) Flow cytometric 
analysis showing the proportion of total CD45+ cells (upper plots) and 
CD45+CD11b+Gr1+ cells (lower plots) in WT (Notch1lox/lox) and Notch1Δ 
cornea 21 days after the repeated injury procedure (see Fig. 1a). Data are 
representative of 6 individual analyses performed on cells pooled from 4 
corneas of each genotype over three independent experiments. (c) Flow 
cytometric analysis showing proportion of total CD45+ cells (upper plots) 
and CD45+CD11b+Gr1+ cells (lower plots) in WT (Notch1lox/lox) and Notch1Δ 
cornea 24 hours after a single injury. Data are representative of 6 individual 
analyses performed on cells pooled from 4 corneas of each genotype over 
three independent experiments. Scale bars represent 500mm.
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Supplementary Figure 2 Chronic inflammation is associated with CSCM in 
Notch1Δ mice. (a) Immunohistochemistry for pS73cjun following repeated 
corneal injury. (b) QRT-PCR analysis for the indicated cytokines in WT 
(Notch1lox/lox:cjunlox/lox), Notch1Δ and Notch1Δ:cjunΔ corneal epithelial cells 
24 hours after a single corneal injury (n = 6 biological replicates for each 
genotype over three independent experiments. Each replicate consists of 
corneal epithelial tissue pooled from 6 corneas isolated from 3 mice of each 
genotype). Data are expressed relative to the expression in WT unwounded 
corneal epithelial cells. (c,d) Quantification of the proportion of CD45+ cells 
in WT (Notch1lox/lox:cjunlox/lox), Notch1Δ and Notch1Δ:cjunΔ cornea 21 days 
after repeated corneal injury (c) or 24 hours after a single corneal injury (d). 
Proportions were measured by performing flow cytometry on dissociated 
corneas.  (n = 6 biological replicates for each genotype over three independent 
experiments. Each replicate consists of cells pooled from 4 corneas isolated 
from 2 mice of each genotype). (e) QRT-PCR analysis of Notch1 in the corneal 
epithelium of WT (Notch1lox/lox:cjunlox/lox), Notch1Δ:cjunΔ and Notch1Δ mice 
following repeated injury (n = 6 biological replicates for each genotype over 
three independent experiments. Each replicate consists of corneal epithelial 
tissue pooled from 6 corneas isolated from 3 mice of each genotype). (f) 
Representative immunofluorescent staining for K12, K1 and CD45 in 
Notch1Δ:cjunΔ and Notch1Δ corneas following repeated corneal injury. Large 
panels are low magnification tiled images. White outlined insets show high 
magnification images of the indicated regions. (g) Proportion of WT (Notch1lox/
lox:cjunlox/lox)(n = 10 corneas), Notch1Δ (n = 20 corneas) and Notch1Δ:cjunΔ 
(n = 16 corneas) corneal tissue exhibiting corneal or epidermal identity after 
repeated corneal injury. (h) Immunfluorescent staining for K12, K1, cjun 
(pS73) and CD45 on corneal tissue isolated from WT (Notch1lox/lox:cjunlox/
lox), Notch1Δ:cjunΔ and Notch1Δ  mice after repeated corneal injury. Data are 
representative of 16 corneas. (i) QRT-PCR analysis of Notch1 in the corneal 
epithelium of WT (Notch1lox/lox) and Notch1Δ mice treated with ophthalmic 
lubricating gel or Tobradex following repeated injury (n = 6 biological 
replicates for each treatment over three independent experiments. Each 
replicate consists of corneal epithelial tissue isolated during corneal wounding 
of a single eye). Scale bars represent 500mm on tiled images and 5mm on 
all other images. St – Stroma. * P <0.01, ** P<0.05 (unpaired, two tailed 
t-tests). Error bars represent standard deviation.
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Supplementary Figure 3 Spatial and temporal kinetics of CSCM (a) 
Representative immunofluorescent staining for K12 and K1 on wholemount 
corneal epithelial tissue isolated from WT and Notch1Δ corneas. Upper 
panels show unwounded corneas, middle panels show corneal epithelial 
tissue 24 hours after the first injury, lower panels show corneal epithelial 
tissue 24 hours after the second injury. Data are representative of 6 corneal 
wholemounts over three independent experiments. (b) XY scatter plots 
showing K12 and K1 expression in limbus, peripheral cornea and central 
cornea in unwounded corneas and in corneas isolated 24 hours after the 
second corneal injury. Each data point represents mean fluorescence intensity 
measured from an individual cornea. Grey boxes = WT (Notch1lox/lox), black 
boxes = Notch1Δ (n = 6 corneas for each genotype over three independent 
experiments). (c) Immunofluorescent staining for Ki67 on WT and Notch1Δ 
corneas. Data are representative of 6 corneas. Upper panels show unwounded 
corneas, middle panels show corneal tissue 24 hours after the first injury, 
lower panels show corneal tissue 24 hours after the second injury. Large 
panels are low magnification tiled images. Insets outlined in green, red and 
yellow show high magnification images of the limbus, peripheral cornea and 
central cornea respectively. (d) Quantification of the proportion of Ki67+ cells 
in the limbus, peripheral cornea and central cornea in unwounded corneas 
(upper panels), corneas 24 hours after the first injury (middle panels) and 
corneas 24 hours after the second injury (lower panels). Black boxes = WT 
(Notch1lox/lox), grey boxes = Notch1Δ (n = 6 corneas for each genotype over 
three independent experiments).  Scale bars represent 500mm on tiled 
images and 5mm on all other images. St – Stroma, Limb – limbus, Per – 
Periphery, Cen – Centre. Error bars represent standard deviation.
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Supplementary Figure 4 Elevated b-catenin is necessary and sufficient 
to induce CSCM. (a-b) Quantification of relative b-catenin expression in 
limbus, peripheral cornea and central cornea in unwounded eyes (a) and 
24 hours after the first injury (b). Black bars = WT (Notch1lox/lox), grey 
bars = Notch1Δ (n = 6 corneas for each genotype over three independent 
experiments). Values for expression levels are relative values normalised 
to the expression level in the conjunctiva of each sample, determined 
by mean fluorescence intensity.  (c) Immunofluorescent staining for 
b-catenin, K12 and K1 on Notch1Δ and Notch1Δ:Ctnnb1Δ corneas after 
repeated injury. Data are representative of 8 corneas for each genotype 
over 3 independent experiments. (d) Immunofluorescent staining for 
b-catenin, K12 and K1 on WT (Ctnnb1lox(Ex3)/lox(Ex3)) and Ctnnb1ΔEx3 
corneas 7 days after a single injury. Data are representative of 8 WT 
corneas and 10 Ctnnb1ΔEx3 corneas over 4 independent experiments. 
(e) Immunofluorescent staining for K12 and K1 on wholemount corneal 
epithelial tissue isolated from or WT (Ctnnb1lox(ex3)/lox(ex3)) or Ctnnb1ΔEx3 
corneas 7 days after a single corneal injury. Data are representative of 6 
WT and 8 Ctnnb1ΔEx3 corneas over 3 independent experiments. Scale 
bars represent 500mm on tiled wholemount images and 5mm on all other 
images. Error bars represent standard deviation.
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Supplementary Figure 5 Inflammation induced CSCM is associated with 
increased ECM deposition in the corneal stroma. (a) QRT-PCR analysis 
of Wnt ligands that exhibit expression in corneal tissue after repeated 
injury. Analysis was performed on whole corneal tissue isolated from WT 
(Notch1lox/lox) and Notch1Δ mice 21 days after the 3rd corneal injury (n = 5 
biological replicates for each genotype over four independent experiments. 
Each replicate consists of corneal epithelial tissue pooled from 4 corneas 
isolated from 2 mice of each genotype). Data are expressed relative to the 
expression in whole corneal tissue isolated from unwounded mice. Error bars 
represent standard deviation. (b) Immunofluorescence for Periostin, CD45 
and DAPI on chronically inflamed Notch1Δ corneal tissue after repeated 
injury. Single fluorescent images and merges are shown as indicated. Data 
are representative of 4 corneas analysed over two independent experiments. 
Scale bars represent 5mm.  (c) Immunofluorescent staining for K14 and 
Tenascin C (upper panels) or K14 and Periostin (lower panels) in Notch1Δ 
mice treated with either ophthalmic gel (control) or Tobradex during the 
repeated injury procedure. Data are representative of 6 corneas analysed over 
three independent experiments. Scale bars represent 500mm.
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Supplementary Figure 6 CSCM is associated with mechanotransduction. 
(a,b) Quantification of FAK phosphorylation (upper panels) and 
nuclear:cytoplasmic ratio of ROCK2 (middle panels) and YAP/TAZ (lower 
panels) in the limbus, peripheral cornea and central cornea isolated from 
unwounded eyes (a) or eyes isolated 24 hours after the first corneal injury 
(b). Values for expression levels are relative values normalised to the 
expression level in the conjunctiva of each sample, determined by mean 
fluorescence intensity. Black bars = WT (Notch1lox/lox), grey bars = Notch1Δ 
(n=6 corneas for each genotype over three independent experiments). Error 
bars represent standard deviation. (c) Immunofluorescence for pFAK, ROCK2 
and YAP/TAZ on corneal tissue isolated from Notch1Δ mice treated with 
ophthalmic gel (control) or Tobradex during the repeated injury procedure. 
Data are representative of 6 corneas for each treatment analysed over three 
independent experiments. Scale bars represent 5mm.
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Supplementary Figure 7 Manipulation of mechanotransduction affects 
b-catenin expression in corneal epithelial cells. (a,b) Immunofluorescence 
for b-catenin, K12 and K1 (a) or YAP/TAZ, K12 and K1 (b) on PCESCs 
cultured on stiff (glass - >2GPa) substrates and maintained in vehicle (PBS 
– upper panels) or 10mM Y27632 (lower panels). Data are representative of 
8 individual cultures for each condition. (c-e) Quantification of b-catenin 
expression (c), YAP/TAZ nuclear:cytoplasmic ratio (d) and the proportion of 
K12+K1- and K12-K1+ cells (e) in PCESCs maintained in vehicle (PBS) or 
10mM Y27632 (n = 8 individual cultures over four independent experiments). 
For (c) b-catenin expression is determined by mean fluorescence intensity. 
(f) Schematic depicting the transfection of TCF-Luc 293 T cells with pR2KD 
or pEGFP. (g) Western blot performed on TCF-Luc 293T cells 48 hours after 
transfection with pR2KD or pEGFP. (h) Relative luciferase activity in TCF-Luc 
293 T cells 48 hours after transfection (n = 6 individual transfections over 
three independent experiments). * P <0.01, ** P<0.05, (unpaired, two tailed 
t-tests). Error bars represent standard deviation. Scale bars represent 20mm.
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